1.5 Diffuse Parenchymal Lung Disease 2016
DOI: 10.1183/13993003.congress-2016.pa3881
|View full text |Cite
|
Sign up to set email alerts
|

Eosinophilic lung disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Eosinophilic lung diseases are a rare group of heterogeneous diseases characterized by increase of the eosinophilic ratio in the airways and lung parenchyma. (1) They are classified as eosinophilic lung diseases of unknown cause including simple pulmonary eosinophilia, acute eosinophilic pneumonia, chronic eosinophilic pneumonia, idiopathic hypereosinophilic syndrome and eosinophilic lung diseases of known cause; including allergic bronchopulmonary aspergillosis, bronchocentric granulomatosis, parasitic infections, drug reactions, eosinophilic vasculitis (allergic angiitis, granulomatosis (Churg-Strauss syndrome) (2). We aimed to present and discuss the clinical, radiologic and pathologic features of patients with eosinophilic lung diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Eosinophilic lung diseases are a rare group of heterogeneous diseases characterized by increase of the eosinophilic ratio in the airways and lung parenchyma. (1) They are classified as eosinophilic lung diseases of unknown cause including simple pulmonary eosinophilia, acute eosinophilic pneumonia, chronic eosinophilic pneumonia, idiopathic hypereosinophilic syndrome and eosinophilic lung diseases of known cause; including allergic bronchopulmonary aspergillosis, bronchocentric granulomatosis, parasitic infections, drug reactions, eosinophilic vasculitis (allergic angiitis, granulomatosis (Churg-Strauss syndrome) (2). We aimed to present and discuss the clinical, radiologic and pathologic features of patients with eosinophilic lung diseases.…”
Section: Introductionmentioning
confidence: 99%